Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.
- DOI
- 10.1016/j.euf.2025.11.011
- Published
- 2026 Jan
- Container
- European urology focus
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.euf.2025.11.011,
title = {Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.},
author = {Cheng HH and Callis S and Yu EY and Delacroix SE and Sokolova AO and Tangen CM and Lerner SP and Dorff TB and Lin DW},
year = {2026},
journal = {European urology focus},
doi = {10.1016/j.euf.2025.11.011},
url = {https://doi.org/10.1016/j.euf.2025.11.011}
}RIS
TY - JOUR TI - Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations. AU - Cheng HH AU - Callis S AU - Yu EY AU - Delacroix SE AU - Sokolova AO AU - Tangen CM AU - Lerner SP AU - Dorff TB AU - Lin DW PY - 2026 JO - European urology focus DO - 10.1016/j.euf.2025.11.011 UR - https://doi.org/10.1016/j.euf.2025.11.011 ER -
APA
HH, C., S, C., EY, Y., SE, D., AO, S., CM, T., SP, L., TB, D., & DW, L. (2026). Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.. European urology focus. https://doi.org/10.1016/j.euf.2025.11.011
Source records
- pubmed · retrieved 2026-09-27T06:43:33.819Z